Active Surveillance for Low-Risk Cancers — A Viable Solution to Overtreatment?

There is wide variation in the intensity of treatment for low-risk cancers, and many patients are at risk for overtreatment. Despite 5-year survival rates that approach 100% among patients with low-risk differentiated thyroid cancer, prostate cancer, and ductal carcinoma in situ (DCIS) of the…

http://ift.tt/2gMbLvA